Traders Alerts: Wireless Xcessories Group, Inc. (OTCMKTS: WIRX), Sumitomo Mitsui Trust Holdings Inc (OTCMKTS: SUTNY), ARCAM AB ORD (OTCMKTS: AMAVF), Provectus Pharmaceuticals, Inc. (OTCMKTS: PVCT)

Lewes, DE -- (SBWire) -- 09/12/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Wireless Xcessories Group, Inc. (OTCMKTS: WIRX), Sumitomo Mitsui Trust Holdings Inc (OTCMKTS: SUTNY), ARCAM AB ORD (OTCMKTS: AMAVF), Provectus Pharmaceuticals, Inc. (OTCMKTS: PVCT).

Wireless Xcessories Group, Inc. (OTCMKTS: WIRX) decreased -22.86% and closed at $1.08 on a traded volume of 107.951 shares, in comparison to 4.460 shares of average trading volume. So far this year, the stock is down over -8.47%.

The company has a total market capitalization of $4.33 million and its total outstanding shares are 4.01 million

Will WIRX Get Buyers Even After The Recent Rally? Find Out Here

Wireless Xcessories Group, Inc. supplies cell phone accessories to dealers, distributors, retailers, agents, and airtime carriers in the United States and Canada.

Sumitomo Mitsui Trust Holdings Inc (OTCMKTS: SUTNY) plunged -0.85% and closed at $4.67 on a traded volume of 78.177 shares, whereas its average trading volume is 118.516 shares. In the last three months, the stock is up 8.6%. The Intra-day range for the stock is $4.61 and $4.72.

Will SUTNY Get Buyers Even After The Recent Rally? Find Out Here

ARCAM AB ORD (OTCMKTS: AMAVF) jumped2.02% and closed at $102.02. So far in three months, the stock is up 98.87%. The 52-week range for the stock is $10.28 and $116.49 and during the previous trading session it marked $103.50 as its highest price. The stock initially exchanged hands with a price of $99.00 and the overall traded volume that day was 13.016 shares.

Will AMAVF Continue To Move Higher? Find Out Here

Arcam AB provides additive manufacturing solutions for the production of metal components.

Provectus Pharmaceuticals, Inc. (OTCMKTS: PVCT) after opening its shares at the price of $0.77 showed no change, close the day at $0.765. The stock ended on a traded volume of 364.559 shares, in comparison to 259.970 shares of average trading volume.

The 52-week range for the stock is $0.43 and $0.89 and during the previous trading session the stock scored the highest price of $0.79.

Can Investors Bet on PVCT after this News update? Find Out Here

Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/328819